Jupiter Topco LLC Invests $7.41 Million in Chemed Corporation $CHE

Key Points

• Jupiter Topco LLC acquired a new $7.41 million stake in Chemed during the second quarter, buying 15,913 shares and owning approximately 0.12% of the company. Institutional investors collectively hold 95.85% of Chemed’s stock.
• Chemed exceeded quarterly expectations, reporting $6.06 in EPS and $673.25 million in revenue, with revenue rising 8.8% year over year. Analysts maintain a consensus “Hold” rating with a $530.75 price target.
• Chemed raised its quarterly dividend to $0.70 per share from $0.60, implying an annualized dividend of $2.80 and a 0.5% yield; insiders have sold 6,537 shares worth roughly $3.41 million over the past 90 days.

Jupiter Topco LLC bought a new stake in Chemed Corporation (NYSE:CHE - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 15,913 shares of the company's stock, valued at approximately $7,412,000. Jupiter Topco LLC owned 0.12% of Chemed at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Geneos Wealth Management Inc. raised its position in Chemed by 330.4% in the first quarter. Geneos Wealth Management Inc. now owns 99 shares of the company's stock valued at $61,000 after purchasing an additional 76 shares during the period. Arrowstreet Capital Limited Partnership boosted its position in shares of Chemed by 67.0% in the second quarter. Arrowstreet Capital Limited Partnership now owns 11,365 shares of the company's stock worth $5,534,000 after buying an additional 4,560 shares during the period. Marshall Wace LLP purchased a new stake in shares of Chemed in the second quarter worth about $579,000. Brown Advisory Inc. grew its stake in shares of Chemed by 36.9% in the second quarter. Brown Advisory Inc. now owns 549 shares of the company's stock valued at $267,000 after buying an additional 148 shares in the last quarter. Finally, Cerity Partners LLC grew its stake in shares of Chemed by 237.7% in the second quarter. Cerity Partners LLC now owns 4,451 shares of the company's stock valued at $2,165,000 after buying an additional 3,133 shares in the last quarter. Institutional investors and hedge funds own 95.85% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on the company. Oppenheimer boosted their price target on Chemed from $500.00 to $590.00 and gave the stock an "outperform" rating in a research report on Friday, July 31st. Bank of America reaffirmed a "neutral" rating on shares of Chemed in a research report on Wednesday, July 29th. Wall Street Zen upgraded shares of Chemed from a "hold" rating to a "strong-buy" rating in a research note on Saturday, August 1st. Royal Bank Of Canada boosted their target price on shares of Chemed from $436.00 to $548.00 and gave the stock a "sector perform" rating in a research report on Thursday, July 30th. Finally, Weiss Ratings upgraded shares of Chemed from a "hold (c-)" rating to a "hold (c)" rating in a research note on Friday, July 17th. One analyst has rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of "Hold" and a consensus price target of $530.75.

Chemed Stock Up 0.0%

Shares of NYSE CHE opened at $523.57 on Monday. Chemed Corporation has a 1 year low of $365.20 and a 1 year high of $557.00. The firm has a market cap of $6.84 billion, a price-to-earnings ratio of 26.30, a PEG ratio of 1.98 and a beta of 0.51. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.89 and a current ratio of 0.91. The stock's 50-day simple moving average is $509.45 and its 200-day simple moving average is $449.68.

Chemed (NYSE:CHE - Get Free Report) last released its quarterly earnings results on Tuesday, July 28th. The company reported $6.06 EPS for the quarter, topping the consensus estimate of $5.60 by $0.46. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The business had revenue of $673.25 million for the quarter, compared to analysts' expectations of $665.04 million. During the same quarter in the previous year, the firm posted $4.27 earnings per share. The company's revenue was up 8.8% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. As a group, equities analysts anticipate that Chemed Corporation will post 23.18 earnings per share for the current fiscal year.

Chemed Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 3rd. Stockholders of record on Monday, August 17th will be paid a dividend of $0.70 per share. This is an increase from Chemed's previous quarterly dividend of $0.60. The ex-dividend date is Monday, August 17th. This represents a $2.80 annualized dividend and a dividend yield of 0.5%. Chemed's dividend payout ratio (DPR) is currently 14.06%.

Insiders Place Their Bets

In related news, Director Andrea R. Lindell sold 1,347 shares of the company's stock in a transaction on Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total value of $602,553.51. Following the sale, the director directly owned 4,578 shares of the company's stock, valued at $2,047,876.74. This represents a 22.73% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Patrick P. Grace sold 190 shares of the company's stock in a transaction on Friday, July 31st. The shares were sold at an average price of $532.00, for a total transaction of $101,080.00. Following the completion of the sale, the director directly owned 3,533 shares in the company, valued at $1,879,556. This represents a 5.10% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 6,537 shares of company stock valued at $3,406,014. Corporate insiders own 3.33% of the company's stock.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corporation (NYSE:CHE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source